• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Dermatology

Direct-access online care model may effectively manage chronic atopic dermatitis

byShirin BajajandAdam Whittington
October 26, 2014
in Dermatology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. When compared to an in-person visit, management of atopic dermatitis via an online care model had similar outcomes.

Evidence Rating Level: 2 (Good)

Study Rundown: Limited access to dermatologic care in select regions has led to the rise of a variety of models for improved access. Teledermatology, the process of communicating dermatologic information electronically, may be able to meet this need. In this study, authors sought to assess the effectiveness of a direct-access online model as compared to an in-person model for the management of atopic dermatitis. Using two metrics looking at disease severity, the authors showed comparable improvement in outcomes for both the in-person and online-care groups. The study’s strength was its randomized control trial design; however, the generalizability was limited as this was a relatively small study that looked at patients with only one chronic skin disease with similar burden of disease.

Click to read the study in JAMA Dermatology

Relevant Reading: Care Partners and Online Patient Portals

In-Depth [randomized controlled trial]: A total of 156 pediatric and adult patients with atopic dermatitis were selected for randomization into either an in-patient or direct-access online group. The patient-oriented eczema measure (POEM) and investigator global assessment (IGA) were used as metrics to assess atopic dermatitis severity. The average age of the direct-access online group and in-person group was comparable at 27.4 and 28, respectively. Using IGA scores, the direct-access online group showed 38.4% (95% CI, 27.7% to 49.3%) of patients achieved near-clearance of their disease as compared to 43.65% (95% CI, 32.6%-54.6%) in the in-person group. The POEM metric demonstrated that the direct-access online group’s scores improved by month 12 from a mean baseline of 13.04 to 7.94 (within group difference of -5.1) as compared to 12.71 to 7.85 (within group difference of -4.86) of the in-person group. The difference in the change in mean POEM scores between the two groups was 0.24 (within the 90% CI of -1.70 – 1.23) indicating that the two interventions met the standards for equivalence.

RELATED REPORTS

Severe atopic dermatitis associated with symptoms of depression and internalizing behaviors in children

#VisualAbstract New RCT (JADE TEEN) shows efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis

#VisualAbstract: Upadacitinib plus topical corticosteroids is safe and effective for moderate-to-severe atopic dermatitis;

More from this author: Tech-aided surveillance of patients at high risk for melanoma aids early diagnosis, Indoor tanning linked to high skin cancer risk in US and abroad, Free drug samples may alter prescription habits of dermatologists, Atopic dermatitis may be more persistent than previously understood

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: dermatitis
Previous Post

Male circumcision associated with reduced syphilis transmission

Next Post

Unexplained infertility often overtreated

RelatedReports

Topical pimecrolimus use for atopic dermatitis not linked to malignancy
Dermatology

Severe atopic dermatitis associated with symptoms of depression and internalizing behaviors in children

September 6, 2021
#VisualAbstract New RCT (JADE TEEN) shows efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis
StudyGraphics

#VisualAbstract New RCT (JADE TEEN) shows efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis

August 26, 2021
#VisualAbstract: Annual screening for ovarian cancer does not significantly reduce mortality
StudyGraphics

#VisualAbstract: Upadacitinib plus topical corticosteroids is safe and effective for moderate-to-severe atopic dermatitis;

June 24, 2021
#VisualAbstract Cutaneous reactions in children treated with MEK and/or BRAF inhibitors are common and often lead to interruptions or alterations in chemotherapy
StudyGraphics

#VisualAbstract Cutaneous reactions in children treated with MEK and/or BRAF inhibitors are common and often lead to interruptions or alterations in chemotherapy

June 10, 2021
Next Post
Unexplained infertility often overtreated

Unexplained infertility often overtreated

Key gut bacteria may prevent Clostridium difficile infection

Key gut bacteria may prevent Clostridium difficile infection

Daily aspirin may not improve overall prostate cancer mortality

Daily aspirin may not improve overall prostate cancer mortality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence may assist in early detection of decreased ejection fraction on echocardiograms
  • #VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
  • Large language models show potential to provide feedback on research papers on a large-scale
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.